» Articles » PMID: 31880291

Human Papilloma Virus Genotypes in Dysplasia and Epithelial Hyperplasia of Oral Cavity Using the Luminex Xmap Technology. A Multicenter Study

Overview
Specialty Dentistry
Date 2019 Dec 28
PMID 31880291
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Oral cancer associated with high risk (HPV-HR) human papilloma virus (HPV) has been increasing. HPV-HR has been associated with epithelial dysplasia, however, little information exists on its frequency in epithelial hyperplasia lesions. The aim of this study is to compare HPV genotypes in dysplastic and hyperplastic lesions of oral cavity.

Material And Methods: Two hundred and fifty oral lesions: 131 dysplasia and 119 hyperplasia from two regions of Colombia were evaluated. One hundred seventy-four coming from urban area and 104 from a high risk population to oral cancer from a rural area. HPV was identified by qPCR and Twenty-four HPVs genotypes were evaluated by Luminex® technology. Logistic regressions were performed to establish the associations between HPV infections with oral dysplasia.

Results: Twenty-eight percent (70/250) of the samples were positives for any HPV and HPV-HRs were more frequently than low risk HPVs. HPV-16 was the most detected genotype (16%) followed by HPV-31, 53, 18 and 45. HPV, HPV-HRs and HPV-16 were only associated with dysplasia in urban area; OR 3.28 (CI 95% 1.49-7.17), OR 7.94 (CI 95% 2.97-21.2) and OR 5.90 (CI 95% 2.05-17). Individuals in rural area showed more HPV and HPV-HRs infection in hyperplasic lesions than urban population. The majority of HPV+ lesions had multi-type of HPV (52/70) and the urban individuals showed more genotypes than rural population.

Conclusions: HPV-.HRs are frequently found in hyperplastic and dysplastic epithelial lesions. HPV-HRs and HPV-16 were associated with dysplasia in urban population. Rural high risk population and urban population differ in the frequency and variety of HPV genotypes.

Citing Articles

Engineering Innovative Interfaces for Point-of-Care Diagnostics.

Burrow D, Heggestad J, Kinnamon D, Chilkoti A Curr Opin Colloid Interface Sci. 2023; :101718.

PMID: 37359425 PMC: 10247612. DOI: 10.1016/j.cocis.2023.101718.


Human papillomavirus, Epstein-Barr virus, and Candida albicans co-infection in oral leukoplakia with different degrees of dysplasia.

Erira A, Navarro A, Robayo D Clin Exp Dent Res. 2021; 7(5):914-923.

PMID: 34101999 PMC: 8543472. DOI: 10.1002/cre2.435.


Identification of HPV16-p16 mediated methylation in oral potentially malignant disorder.

Buenahora M, Lafaurie G, Perdomo S Epigenetics. 2020; 16(9):1016-1030.

PMID: 33164635 PMC: 8451454. DOI: 10.1080/15592294.2020.1834923.

References
1.
Szentirmay Z, Polus K, Tamas L, Szentkuti G, Kurcsics J, Csernak E . Human papillomavirus in head and neck cancer: molecular biology and clinicopathological correlations. Cancer Metastasis Rev. 2005; 24(1):19-34. DOI: 10.1007/s10555-005-5045-3. View

2.
Bui T, Tran L, Thai T, Shete S, Vidrine D, Sturgis E . Prevalence of and Risk Factors for Oral Human Papillomavirus Infection With Multiple Genotypes in the United States. Sex Transm Dis. 2017; 44(3):166-172. PMC: 6710830. DOI: 10.1097/OLQ.0000000000000563. View

3.
Campisi G, Panzarella V, Giuliani M, Lajolo C, Di Fede O, Falaschini S . Human papillomavirus: its identity and controversial role in oral oncogenesis, premalignant and malignant lesions (review). Int J Oncol. 2007; 30(4):813-23. View

4.
Chen X, Zhao Y . Human papillomavirus infection in oral potentially malignant disorders and cancer. Arch Oral Biol. 2017; 83:334-339. DOI: 10.1016/j.archoralbio.2017.08.011. View

5.
Tam S, Fu S, Xu L, Krause K, Lairson D, Miao H . The epidemiology of oral human papillomavirus infection in healthy populations: A systematic review and meta-analysis. Oral Oncol. 2018; 82:91-99. DOI: 10.1016/j.oraloncology.2018.04.005. View